Skip to content

Comparing effectiveness of two injections in preventing fall in BP after spinal anaesthesia in Caesarean section

A Prospective Randomised double blinded study to compare the efficacy of prophylactic intravenous administration of Ondansetron 4 mg and granisetron 3mg for attenuation of spinal induced hypotension in parturients undergoing elective lower segment Caesarean section - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/086787
Enrollment
100
Registered
2025-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Group O: Intravenous ondansetron 4mg, 5 minutes before spinal anaesthesia in parturients undergoing elective LSCS Control Intervention1: Group G: Intravenous Granisetron 3mg, 5 minutes

Sponsors

Sushma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Parturients belonging to ASA grade 1 and 2 with more than 36 weeks gestation undergoing elective LSCS for a singleton pregnancy with Height 150 - 170cm.

Exclusion criteria

Exclusion criteria: Patient refusal Parturients with spinal deformity Parturients with medical and obstretric complications like anemia, cardiac disease, gestational hypertension, gestational diabetes, shock, liver disorders, septicemia and hypertension. Known hypersensitivity to local anaesthetics and study drugs. Subjects having any absolute or relative contraindications for spinal anaesthesia like raised intracranial pressure, severe hypovolemia, bleeding diathesis and local infection. Parturients with BMI more than 30 On drugs like selective serotonin reuptake inhibitors and migraine medications. Intraoperative blood loss more than1 litre

Design outcomes

Primary

MeasureTime frame
Comparison of hemodynamic parameters like systolic blood pressure and heart rateTimepoint: 2,4,6,8,10,15,20,25,30,35,40,50,60,70,80,90 minutes and till 3 hours postoperative period

Secondary

MeasureTime frame
To assess total requirement of intravenous ephedrine to treat hypotension and to assess intravenous atropine to treat bradycardia to assess incidence of nausea vomiting and intra operative and post operative shiveringTimepoint: 2,4,6,8,10,15,20,25,30,35,40,50,60,70,80,90 minutes and till 3 hours postoperative period

Countries

India

Contacts

Public ContactDr B C Vijayalakshmi

Mysore medical college and research institute, mysuru

vijayanagaraj@yahoo.co.in9886239622

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026